Latest FMTX reports update at 2023-12-23: 2022-Q2 ∙ 2022-Q1 ∙ 2021-Q4

Forma Therapeutics Holdings FMTX

$ 20.01 0.0%

Forma Therapeutics Holdings Balance Sheet 2011-2024 | FMTX

Annual Balance Sheet Forma Therapeutics Holdings

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-44.7 M	-	-	-83.4 M	-	-	-	-	-	-	-
Long Term Debt	27.6 M	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	5.12 M	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	1.03 M	2.62 M	11.9 M	-	-	-	-	-	-	-
Total Current Liabilities	35.1 M	31.7 M	24.9 M	-	-	-	-	-	-	-	-
Total Liabilities	62.7 M	32.7 M	26.7 M	246 M	-	-	-	-	-	-	-
Deferred Revenue	-	1.24 M	1.24 M	203 M	-	-	-	-	-	-	-
Retained Earnings	-230 M	-57.4 M	16.7 M	-54.6 M	-	-	-	-	-	-	-
Total Assets	561 M	681 M	183 M	263 M	-	-	-	-	-	-	-
Cash and Cash Equivalents	77.4 M	283 M	174 M	-	-	-	-	-	-	-	-
Book Value	498 M	648 M	156 M	17.6 M	-	-	-	-	-	-	-
Total Shareholders Equity	498 M	648 M	18.2 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Forma Therapeutics Holdings

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	27 M	27.6 M	26.8 M	2.87 M	-	-	5.21 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	60.7 M	53.3 M	62.7 M	59.4 M	34 M	-	32.7 M	32.7 M	29 M	32.7 M	26.7 M	26.7 M	26.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	1.24 M	-	-	1.24 M	1.24 M	1.24 M	6.43 M	-	94 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-327 M	-275 M	-230 M	-180 M	-137 M	-	-57.4 M	-57.4 M	-1.21 M	-57.4 M	16.7 M	16.7 M	16.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	-	-	475 M	514 M	561 M	602 M	613 M	-	681 M	681 M	468 M	681 M	183 M	183 M	183 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	-	-	74.4 M	77.4 M	87.2 M	50.9 M	97.8 M	283 M	283 M	283 M	283 M	173 M	173 M	173 M	-	84.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-	-	414 M	461 M	498 M	543 M	579 M	-	648 M	648 M	438 M	648 M	156 M	156 M	156 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	-	414 M	461 M	498 M	543 M	579 M	616 M	648 M	416 M	438 M	28.8 M	18.2 M	18.2 M	83.4 M	98.2 M	-48.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency